These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 27329556)
1. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology. Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556 [TBL] [Abstract][Full Text] [Related]
2. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584 [TBL] [Abstract][Full Text] [Related]
3. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions. Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157 [TBL] [Abstract][Full Text] [Related]
4. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257 [TBL] [Abstract][Full Text] [Related]
5. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809 [TBL] [Abstract][Full Text] [Related]
6. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat. Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811 [TBL] [Abstract][Full Text] [Related]
7. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology. Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676 [TBL] [Abstract][Full Text] [Related]
8. The dopamine reuptake inhibitor MRZ-9547 increases progressive ratio responding in rats. Sommer S; Danysz W; Russ H; Valastro B; Flik G; Hauber W Int J Neuropsychopharmacol; 2014 Dec; 17(12):2045-56. PubMed ID: 24964269 [TBL] [Abstract][Full Text] [Related]
9. The dopamine depleting agent tetrabenazine alters effort-related decision making as assessed by mouse touchscreen procedures. Yang JH; Presby RE; Rotolo RA; Quiles T; Okifo K; Zorda E; Fitch RH; Correa M; Salamone JD Psychopharmacology (Berl); 2020 Sep; 237(9):2845-2854. PubMed ID: 32561947 [TBL] [Abstract][Full Text] [Related]
10. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935 [TBL] [Abstract][Full Text] [Related]
11. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine. Presby RE; Rotolo RA; Hurley EM; Ferrigno SM; Murphy CE; McMullen HP; Desai PA; Zorda EM; Kuperwasser FB; Carratala-Ros C; Correa M; Salamone JD Pharmacol Biochem Behav; 2021 Mar; 202():173115. PubMed ID: 33493546 [TBL] [Abstract][Full Text] [Related]
12. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior. Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139 [TBL] [Abstract][Full Text] [Related]
13. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131 [TBL] [Abstract][Full Text] [Related]